Aardvark Therapeutics
AARD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Aardvark Therapeutics(AARD) predict that the EBIT is -22.46 M (-114.6%), Miss estimate;the EPS is -0.99 (-39.44%), Miss estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
TBA--
0.00B--
----
EBITMiss expectations
-0.02B114.56%
-0.02B81.66%
-0.00B32.90%
EPSMiss expectations
-0.9939.44%
-0.8925.35%
-0.100014.09%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf